2 months ago
EWTX
AnalystsTessa RomeroTessa Romero's Stock Forecasts
AnalystsTessa Romero
Sectors:
Industries:
Analyst Ranking
Top 13%
#649 out of 5272 analysts
Average Return
+19.74%
Win Rate
51%33 out of 65
Risk vs Reward
Poor
Good
Tessa Romero's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Scholar Rock Holding CorpSRRK | +397.74% | $7.07 | $35.19 | 2024-10-02 - 2025-10-02 | Strong Buy |
Dyne Therapeutics IncDYN | +307.09% | $10.58 | $43.07 | 2023-08-08 - 2024-08-08 | Strong Buy |
Biohaven LtdBHVN | +174.33% | $14.65 | $40.19 | 2023-01-03 - 2024-01-03 | Strong Buy |
Edgewise Therapeutics IncEWTX | +155.94% | $13.80 | $35.32 | 2025-08-18 - 2026-05-08 | Strong Buy |
Edgewise Therapeutics IncEWTX | +132.39% | $7.75 | $18.01 | 2023-06-29 - 2024-06-28 | Strong Buy |
Tessa Romero Analyst Color
Get additional color on Tessa Romero's coverage of popular stocks
2 months ago
SRRK
2 months ago
ACAD
4 months ago
XENE
6 months ago
XENE
6 months ago
SRRK
6 months ago
EWTX
2 years ago
BHVN
2 years ago
CYTK
2 years ago
BHVN
Tessa Romero's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Agios Pharmaceuticals IncAGIO | 9 | Hold | $36.00 | +29.54% | Maintains | a month ago |
Septerna IncSEPN | 1 | Strong Buy | $38.00 | +59.20% | Maintains | 2 months ago |
Edgewise Therapeutics IncEWTX | 11 | Strong Buy | $45.00 | +27.41% | Maintains | 2 months ago |
Cytokinetics IncCYTK | 7 | Strong Buy | $75.00 | -2.48% | Maintains | 2 months ago |
Scholar Rock Holding CorpSRRK | 6 | Strong Buy | $50.00 | +3.33% | Maintains | 2 months ago |
Acadia Pharmaceuticals IncACAD | 12 | Strong Buy | $34.00 | +51.79% | Maintains | 2 months ago |
Dyne Therapeutics IncDYN | 8 | Hold | $16.00 | -9.14% | Maintains | 4 months ago |
Xenon Pharmaceuticals IncXENE | 4 | Strong Buy | $62.00 | +9.85% | Maintains | 4 months ago |
Oculis Holding AgOCS | 1 | Strong Buy | $38.00 | +16.42% | Initiates Coverage On | 5 months ago |
Biohaven LtdBHVN | 8 | Strong Buy | $15.00 | +52.13% | Maintains | 6 months ago |
Rocket Pharmaceuticals IncRCKT | 1 | Strong Sell | $263.00 | +7,145.18% | Downgrades | 6 months ago |
Lexeo Therapeutics IncLXEO | 2 | Strong Buy | $10.00 | +71.53% | Maintains | a year ago |
Upstream Bio IncUPB | 1 | Strong Buy | $38.00 | N/A | Initiates Coverage On | 2 years ago |
Neumora Therapeutics IncNMRA | 4 | Hold | $15.00 | N/A | Downgrades | 2 years ago |
Eyepoint IncEYPT | 3 | Strong Buy | $29.00 | N/A | Maintains | 2 years ago |
Y Mabs Therapeutics IncYMAB | 5 | Strong Sell | $7.00 | N/A | Maintains | 3 years ago |
Seres Therapeutics IncMCRB | 1 | Hold | $140.00 | N/A | Initiates Coverage On | 3 years ago |
Global Blood Therapeutics IncGBT | 2 | Hold | $36.00 | N/A | Maintains | 4 years ago |
Orchard Therapeutics PLCORTX | 1 | Strong Buy | $150.00 | N/A | Assumes | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.